[go: up one dir, main page]

Beyond exon 2--the developing story of RAS mutations in colorectal cancer

N Engl J Med. 2013 Sep 12;369(11):1059-60. doi: 10.1056/NEJMe1307992.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Colorectal Neoplasms / genetics*
  • ErbB Receptors / antagonists & inhibitors*
  • Fluorouracil / therapeutic use
  • Genes, ras*
  • Humans
  • Leucovorin / therapeutic use
  • Organoplatinum Compounds / therapeutic use
  • Panitumumab
  • Proto-Oncogene Proteins / genetics*
  • Proto-Oncogene Proteins B-raf / genetics*
  • Proto-Oncogene Proteins p21(ras)
  • ras Proteins / genetics*

Substances

  • Antibodies, Monoclonal
  • KRAS protein, human
  • Organoplatinum Compounds
  • Proto-Oncogene Proteins
  • Panitumumab
  • ErbB Receptors
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf
  • Proto-Oncogene Proteins p21(ras)
  • ras Proteins
  • Leucovorin
  • Fluorouracil

Supplementary concepts

  • Folfox protocol